Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

All articles and reminders · November 15, 2026

Published November 15, 2026 · Reporting window November 8–14, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

All articlesSearch this edition →

66 articles and reminders, grouped by category.

Compliance Sweep

Higher-priority matters

Payment & health plan rules 2 articles and reminders

Payment & health plan rulesCompliance SweepNew in this edition

Federal IDR dispute web forms move into the IDR Gateway; disputes cannot start outside it after January 15, 2027

CMS's About Independent Dispute Resolution page, last modified November 13, 2026, says that as of November 13, 2026, users of the independent dispute resolution (IDR) Gateway can submit the Notice of IDR Initiation, IDR Entity Selection Response and Notice of Offer web forms in the Gateway. The single-use web forms will no longer be available outside the IDR Gateway after January 15, 2027, and parties will not be able to start a dispute outside the Gateway after that date. Organizations and individuals that process disputes, represent parties or submit IDR web forms must sign up to continue managing disputes in the IDR Gateway.

Medium priority · Nov 15, 2026 editionRead story →

Payment & health plan rulesCompliance SweepUpdated

CMS publishes CARE proposed rule (CMS-3484-P) in the Federal Register; comments assured consideration if received by January 11, 2027

The Federal Register published the Cutting Administrative Requirements for Excellence in Patient Care (CARE) proposed rule on November 10, 2026 at 91 FR 72634 (FR Doc. 2026-22812, docket CMS-3484-P). Its Dates section states that, to be assured consideration, comments must be received by January 11, 2027. The Federal Register record, read on November 15, 2026, lists no corrections. Nothing in the proposal is final; CMS's November 5, 2026 fact sheet describes the obstetric requirements it would remove as otherwise effective January 1, 2027; they would be removed only if CMS finalizes the proposal.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operations 14 articles and reminders

Governance & business operationsCompliance SweepUpdated

Medline bed recall: seven deaths and 35 serious injuries now reported; repair-and-replace customer guides coming

On November 13, 2026, FDA posted a Medline company announcement updating customers and patients on the repair and replace program for the recall of Medline Brand beds, rails, mattresses and accessories. Medline says that as of November 8, 2026 it has received reports related to seven deaths and 35 serious injuries associated with the fire hazard and entrapment issues, up from the two deaths and 16 serious injuries FDA's early alert reported as of October 20, 2026. Medline says it distributed the products in the United States and Canada between 2011 and 2026 to durable medical equipment providers, long-term care facilities and end users, and that it will soon begin distributing new repair and replace Customer Guides to patients and users. The continued-use instructions are unchanged: unplug the beds, plug in only while repositioning the patient, do not use extension cords, and have a second person assist whenever possible. To determine eligibility for repair, replacement or refund, customers contact the provider or distributor they bought or received the bed from, or Medline Recall Customer Service if they bought directly from Medline. On November 15, 2026, FDA's early alert page still showed content current as of October 29, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Arrow International removes catheters and guidewires with hydrophilic-coated spring wire guides over coating detachment and embolism risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Arrow International, a subsidiary of Teleflex Incorporated, which has told customers to remove certain products that contain Spring Wire Guide components. Arrow sent the letter on November 5, 2026, telling customers to check inventory, stop using and distributing affected product, quarantine it and return it. Teleflex confirmed that the hydrophilic coating may swell unevenly when hydrated with saline, clump and potentially detach. Detached coating could release particles into the bloodstream and raise the risk of emboli. As of November 5, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Intersurgical removes lots of 22mm Smoothbore breathing tubes and systems over connector disconnection and loss of ventilation risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Intersurgical Inc., which has told customers to remove listed lots of its 22mm Smoothbore breathing tubes and systems. Intersurgical sent the letter on November 3, 2026, telling customers to stop using and quarantine stock with the affected product and lot numbers and return it. Testing of internal stock found some products were made with too little solvent to secure the soft connectors to the tube. A connector that disconnects during use could cause loss of ventilation or compromised ventilation. As of November 3, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate

Eugia US LLC announced on November 6, 2026 a voluntary nationwide recall, to the hospital/healthcare facility/user level, of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL because a glass particle was found inside a vial; FDA posted the announcement on November 9, 2026. The lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and holders are told to discontinue use and quarantine it immediately.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

OHCA first-year provisional NOLA (labor-cost adjustment) requests still due November 16, 2026

California's Office of Health Care Affordability (OHCA) enforces health care spending targets set by its Health Care Affordability Board, and the law lets the Board adjust targets when non-supervisory organized labor costs are expected to grow faster than the target, through a Non-Supervisory Organized Labor Adjustment (NOLA). For the first year, OHCA must receive all requests for a provisional NOLA by November 16, 2026 (by the end of October in future years). NOLAs apply to providers and fully integrated delivery systems, not health plans; a labor union may initiate a request but the regulated entity must attest, and all NOLAs are provisional until confirmed with actual expenditure data.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

HemosIL AcuStar HIT-IgG(PF4-H) lot recall: destroy listed lots and document on the response form

FDA identified as the most serious type of recall the removal of four lots of an assay that, with other laboratory and clinical findings, aids in determining the risk for heparin-induced thrombocytopenia (HIT): HemosIL AcuStar HIT-IgG(PF4-H), from Instrumentation Laboratories (Werfen). Werfen found a performance issue in lots B40005, B40006, B38062 and B38063 that may cause a negative bias, so sample results could be incorrectly reported below the assay cut-off (1.00 U/mL) and be interpreted as HIT IgG antibody negative. The earlier article reported FDA's listing of the confirmed recall on October 30, 2026, and FDA says a supply interruption is expected.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

FDA early alert: ButterflyBVM bag-valve-mask resuscitators, removal of lots 000109 to 000117 and pre-use test for others

The Food and Drug Administration (FDA) issued an Early Alert on November 3, 2026 about Compact Medical's "Urgent Medical Device Recall" for certain lots of ButterflyBVM single-use bag-valve-mask resuscitators: lots 000109 through 000117 are to be removed, and listed earlier lots get a correction, to perform the Pre-Use Test before every use and not use any unit that fails. A hole can form in the bellows, which FDA says can cause inadequate ventilation and hypoxia; the firm sent letters on September 26 and October 7, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

StatStrip Gen 2.0 glucose meter Class I correction: interim safeguards until the software update

FDA identified Nova Biomedical's correction of its StatStrip Glucose Hospital Meter System as the most serious type of recall (Class I): on the Gen 2.0 model only, prior patient or quality-control information may remain on the meter screen when a barcode is scanned and, if accepted, assign a glucose result to the wrong patient. FDA issued its communication on October 20, 2026 and updated it on October 30 to clarify the recommended actions. Nova intends to roll out a software update in November 2026 in a phased manner; until then users follow updated instructions or, if an alternative meter is available, stop using the affected meter.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

B. Braun Dialog+ bloodline early alert: three Streamline Bloodline Set lots removed over connector detachment risk

FDA issued an Early Alert on a potentially high-risk device issue: B. Braun Medical Inc. has recommended to customers that lots A2600099, A2600128 and A2600136 of its Streamline Bloodline Set for Dialog+, model SL-2010M2096, be removed from where they are used or sold. B. Braun stated that a required solvent application step during assembly was not performed, leaving the dialyzer connector inadequately bonded, so the bloodline connector may detach or leak during priming or dialysis treatment, potentially leading to blood loss, clotting and occlusion of the extracorporeal circuit, or air entering the blood circuit. B. Braun sent customers a letter on October 20, 2026, and the earlier article reported FDA's device-safety listing of the alert on October 27, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Transparency in Coverage final rule: phased machine-readable file and phone-disclosure duties still ahead

The Transparency in Coverage final rule (FR Doc. 2026-20447, 91 FR 63748), published in the Federal Register on October 6, 2026 and effective December 7, 2026, sets new disclosure duties for non-grandfathered group health plans and health insurance issuers: in-network rate files for each provider network, out-of-network allowed-amount files for each health insurance market, new contextual files, a website footer link labeled Price Transparency or Transparency in Coverage, attestations in the files, and cost-sharing information available by phone. The duties phase in for plan years (policy years in the individual market) beginning on or after January 1, 2027 (the amended cost-sharing disclosures, including the phone method), on March 6, 2027 (the rate and allowed-amount file changes and attestations) and on September 6, 2027 (the contextual files and footer), with the first utilization file due July 1, 2028; until each date the prior rules continue to apply.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepUpdated

CDPH submits readoption of acute psychiatric hospital nurse-to-patient ratio emergency regulations to OAL

The Office of Administrative Law (OAL) lists a California Department of Public Health (CDPH) emergency action titled Acute Psychiatric Hospitals, amending Title 22 sections that OAL lists as 71213 and 71215 (CDPH's October 30, 2026 All Facilities Letter names sections 71213.1 and 71215.1, and this difference was not resolved), as submitted on November 9, 2026 under OAL file 2026-1109-02EEFP. OAL's list covers proposed emergency actions that have been submitted and are currently under review. OAL must allow five calendar days for public comments after posting notice of an emergency filing, unless the emergency situation clearly poses such an immediate, serious harm that delaying action to allow public comment would be inconsistent with the public interest. On November 15, 2026, OAL had not posted a decision, and CDPH's rulemaking page for DPH-19-001E still showed only the original emergency history.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA lists a Class I recall of four lots of the Edwards Commander M mitral valve delivery system over a manufacturing issue that may cause balloon rupture

The U.S. Food and Drug Administration's (FDA) Enforcement Report for the week of November 11, 2026 lists a Class I recall by Edwards Lifesciences, LLC of the Edwards Commander M Delivery System, model 9880CM29A, a delivery system for a percutaneously delivered mitral valve prosthesis. The recall covers lot numbers 67718561, 67804014, 67887043 and 67887044. The reason given is a manufacturing issue which may result in cardiovascular balloon rupturing.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

OHCA amended material change transaction rules took effect November 2; HCAI posts filing flowchart for management services organizations

The laws and regulations page of the Department of Health Care Access and Information (HCAI) states that the Office of Administrative Law approved amendments to the Office of Health Care Affordability (OHCA) Material Change Transactions and Pre-Transaction Review regulations, used for cost and market impact review (CMIR), on October 2, 2026, with a November 2, 2026 effective date (California Code of Regulations, title 22, sections 97431 through 97442). On November 10, 2026, HCAI posted a flowchart, marked New 11/2026, on when a management services organization (MSO) must file a material change transaction notice; it says it was developed for the regulations effective November 2, 2026. Under the flowchart, one threshold is an MSO owned by a hospital with one or more physician organization clients or affiliates. The approved text requires a health care entity or noticing entity that meets the filing criteria to give OHCA notice at least 90 days before the closing date of the transaction.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

California regulator tells health plans how downcoding must be disclosed and reviewed, with plan filings due November 23

On October 23, 2026, the California Department of Managed Health Care (DMHC) issued All Plan Letter (APL) 26-015 to all licensed health care service plans on downcoding, which the letter defines as paying a claim at a less complex or lower level of service than the provider billed. Plans must disclose the criteria and methods they use to pick claims for downcoding and to set the adjusted level, must review all supplemental documentation the provider submitted, which may include medical records, before downcoding, and must pay the portion of a claim the documentation supports. Each plan that has implemented or seeks to implement downcoding must make one compliance filing with DMHC by November 23, 2026.

Medium priority · Nov 15, 2026 editionRead story →

More matters and continuing watch

AI & digital health 1 articles and reminders

Governance & business operations 10 articles and reminders

Enforcement Briefing

Higher-priority matters

Billing fraud & false claims 4 articles and reminders

Billing fraud & false claimsEnforcement BriefingNew in this edition

OIG posts seven October self-disclosure settlements; Northwestern Memorial Hospital agrees to pay $315,335.93 to resolve allegations over services by unlicensed staff

OIG posted seven settlements dated October 5 to October 30, 2026 that followed providers' own disclosures. Northwestern Memorial Hospital, Chicago, agreed to pay $315,335.93 to resolve allegations that it billed Federal health care programs for services by an unlicensed clinical dietician, two unlicensed clinical nurses and an unlicensed registered nurse; single damages were calculated as the full salary and benefits paid while they worked without valid licenses. Three other settlements also resolve allegations involving unlicensed nurses: an oncology practice group ($249,773.98), Fountain Bleu ($103,128.49) and Melbourne Healthcare and Rehabilitation Center ($43,693.56). The remaining settlements resolve allegations of claims for audiology services billed using audiologists' billing information but furnished by a person not enrolled in Medicare (Arizona Otolaryngology Consultants), claims for certain laparoscopic surgical procedures that were not medically necessary (Swedish Medical Group) and payments to a physician for medical director services not performed and for services outside the medical director agreement (Home Health Care Services II and Advanced Technologies in Home Care, $105,750).

High priority · Nov 15, 2026 editionRead story →

Billing fraud & false claimsEnforcement BriefingConditional reminder

DOJ reports California physician Violetta Mailyan sentenced to 15 years in prison in Medicare Botox billing case

A federal court sentenced California physician Violetta Mailyan to 15 years in prison on October 29, 2026, DOJ announced on October 30. DOJ reports that she used her medical practice to fraudulently bill Medicare more than $45 million for Botox injection services that were medically unnecessary and never provided, and that after a six-day jury trial ending in May 2026 she was convicted of nine counts of wire fraud and three counts of obstruction of a criminal investigation of a health care offense. The court ordered $32,904,049.41 in restitution to Medicare and the immediate forfeiture of over $16,029,742 worth of seized property.

High priority · Nov 15, 2026 editionRead story →

Billing fraud & false claimsEnforcement BriefingConditional reminder

Adult day-care owner pleads guilty in $65 million Medicaid scheme

Ahsan Ijaz, an owner of two social adult day care centers and a home health care fiscal intermediary in Brooklyn, New York, pleaded guilty to conspiracy to commit health care fraud, the Justice Department announced on October 2, 2026. DOJ reports that he pleaded guilty to defrauding New York State Medicaid of approximately $65 million through claims for social adult day care and home health care services that were not provided; according to court documents, the businesses paid cash kickbacks and bribes to Medicaid recipients to induce enrollment and billed for services not provided, including when certain Medicaid recipients were not in the United States at the time of service. Sentencing is scheduled for March 10, 2027.

High priority · Nov 15, 2026 editionRead story →

Billing fraud & false claimsEnforcement BriefingNew in this edition

Adventist Health Sierra Vista agrees to pay $67,030.59 to OIG to resolve allegations it employed an excluded individual, disclosed under its Corporate Integrity Agreement

OIG posted a settlement with Sierra Vista Hospital, Inc. d/b/a Adventist Health Sierra Vista, San Luis Obispo, California, for $67,030.59. The hospital self-disclosed the conduct to OIG under its Corporate Integrity Agreement (CIA). The settlement resolves allegations that the hospital employed an individual it knew or should have known was excluded from Federal health care programs. OIG dates the action September 15, 2026. Separately, OIG's What's New page lists an update of its CIA Reportable Events listing on November 13, 2026, and that listing, as read on November 15, 2026, includes this entry; the sources do not show which entry the update added.

Medium priority · Nov 15, 2026 editionRead story →

Health plan oversight 1 articles and reminders

Health plan oversightEnforcement BriefingNew in this edition

DMHC orders Astiva Health to stop adding enrollees over tangible net equity shortfalls

On November 9, 2026, the California Department of Managed Health Care (DMHC) issued an Order to Cease and Desist in enforcement matter 26-069 against Astiva Health, Inc., a health plan it licenses. The order directs Astiva to cease accepting the assignment or addition of enrollees without the Director's prior written approval, and it took effect immediately. It does not apply to dependents of current enrollees or to enrollees who chose the plan during an open enrollment or other selection period before the prohibition took effect. Astiva must file a Verified Statement affirming compliance by December 9, 2026. Separately, paragraph 21 of the order says Astiva shall file documentation with DMHC no later than 60 calendar days from the date of the order that clearly sets forth how Astiva is operating in compliance with the order.

Medium priority · Nov 15, 2026 editionRead story →

More matters and continuing watch

Billing fraud & false claims 9 articles and reminders

Consumer & business misconduct 1 articles and reminders

Medicare & Medicaid Sweep

Higher-priority matters

Billing & payment 5 articles and reminders

Billing & paymentMedicare & Medicaid SweepUpdated

CMS issues contractor instructions for the CY 2027 ESRD PPS: low-volume adjustment tiers and December 31, 2026 attestation deadline

On November 12, 2026 CMS issued Transmittal R14043BP (Change Request 14638), the annual update that implements the calendar year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rate updates and policies for Medicare contractors, effective January 1, 2027 with implementation January 4, 2027. It states the CY 2027 base rate of $297.52, expands the low-volume payment adjustment (LVPA) to facilities furnishing fewer than 8,000 treatments in each of the past three cost-reporting years, in six tiers, and extends the LVPA attestation deadline to December 31, 2026: facilities must attest by that date to receive the adjustment for payment year 2027, unless extraordinary circumstances justify an exception. It directs Medicare contractors to extend the attestation deadline for payment year 2027 to December 31, 2026. A companion systems transmittal, R13909CP (Change Request 14551), dated August 7, 2026, was re-communicated on November 13, 2026, with a note that it may now be posted publicly; the CMS transmittals index lists it with an issue date of November 12, 2026. On November 15, 2026 the Federal Register record for the rule still gave an effective date of January 1, 2027 and listed no corrections.

High priority · Nov 15, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepConditional reminder

CMS issues CY 2027 Physician Fee Schedule final rule (CMS-1848-F): conversion factors fall, same-day E/M and 0-day global payment cut, new 340B Part D claims repository duty

CMS finalized the calendar year (CY) 2027 Physician Fee Schedule (PFS) rule, CMS-1848-F, published November 9, 2026 and effective January 1, 2027. It lowers both conversion factors, cuts payment when an office or outpatient evaluation and management (E/M) visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it), and requires 340B covered entities to submit claim data to a CMS repository for units of covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, for dates of service from January 1, 2027, with the first quarterly submission due September 30, 2027.

High priority · Nov 15, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepConditional reminder

Medicare to pay ASP minus 28 percent, or another set basis where ASP is unavailable, for separately payable 340B-acquired drugs at non-exempt hospitals from January 1, 2027 (pass-through drugs, vaccines and non-opioid pain relief drugs excluded); every separately paid OPPS drug line must carry modifier JG, TB or ND

In the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) final rule, published November 6, 2026, CMS will pay average sales price (ASP) minus 28 percent for separately payable drugs acquired under the 340B Program at non-exempt hospitals from January 1, 2027 when ASP is available; where ASP is not available, payment is based on wholesale acquisition cost (WAC) minus 28 percent, then 64.53 percent of average wholesale price (AWP), then 100 percent of mean unit cost (MUC), then the invoice price, and certain products such as nonpass-through diagnostic radiopharmaceuticals with claims data continue to be paid on arithmetic MUC; pass-through drugs, vaccines and non-opioid pain relief drugs are excluded, and rural sole community hospitals (SCHs), children's hospitals and cancer hospitals exempt from the prospective payment system (PPS) are exempt. From the same date every separately paid OPPS drug claim line, billed under its Healthcare Common Procedure Coding System (HCPCS) code, must carry modifier JG, TB or ND.

High priority · Nov 15, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepUpdated

CMS posts home health grouper Version 08.0.27 for January 2027 claims

The November 12, 2026 Medicare Learning Network (MLN) Connects newsletter announced the January 2027 release of the Home Health Prospective Payment System Grouper, Version 08.0.27, and pointed to the grouper software webpage for a summary of changes. On November 15, 2026 the CMS 2026 transmittals index still listed the instruction, R13974CP, Quarterly Update to Home Health (HH) Grouper, with implementation January 4, 2027.

Medium priority · Nov 15, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepNew in this edition

CMS extends nationwide Medicare enrollment moratoria on new home health agencies and hospices but again allows branches and new practice locations

The Centers for Medicare & Medicaid Services (CMS) extended and modified its nationwide temporary moratoria on Medicare enrollment of new home health agencies (HHAs) and new hospices, effective November 12, 2026, in two notices filed for public inspection on November 12 and scheduled for Federal Register publication on November 16, 2026. During the 6-month extension the moratoria apply only to initially enrolling HHAs and hospices, including those that must enroll anew after a change in majority ownership (CIMO). The moratoria on adding HHA branches and new hospice practice locations by currently enrolled agencies end as of November 12, 2026. CMS said it consulted the HHS Office of Inspector General (OIG), which agreed there remains a significant potential for fraud, waste or abuse, and it considered and rejected limiting the HHA extension to southern California.

Medium priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policy 6 articles and reminders

Medi-Cal & Medicaid policyMedicare & Medicaid SweepConditional reminder

Medi-Cal youth gender-affirming services (APL 26-018): federal reimbursement limit from October 13, 2026 and hormone transition through April 12, 2027

Department of Health Care Services (DHCS) All Plan Letter (APL) 26-018, Federal Reimbursement Limitation on Gender-Affirming Care Services for Youth, is listed in the DHCS letter index with the date 09/30/2026. As the October 11 article reported it, the letter limits reimbursement from October 13 for specified gender-affirming surgery, puberty blockers and hormone therapy for Medi-Cal members under 18 and Children's Health Insurance Program (CHIP) members under 19 (services for other medical indications and treatment of complications remain covered when medically necessary), keeps a transition through April 12, 2027 for hormones already being taken as of October 13 (for affected plan members, only under the medical benefit), and requires plans to submit policies, an attestation and copies within 90 calendar days of release, which the article gave as December 29.

High priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policyMedicare & Medicaid SweepConditional reminder

DHCS notice (October 9): Medi-Cal clinic institutional claims submitted from October 15 require diagnosis codes

In a notice published October 9, 2026, the Department of Health Care Services (DHCS) said that for all Medi-Cal claims submitted on or after October 15, 2026, at least one clinically appropriate International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code is required on a UB-04 claim form or the 837I electronic form by Federally Qualified Health Centers (FQHCs), Rural Health Clinics (RHCs), Indian Health Services (IHS) Memorandum of Agreement (MOA) 638 providers and Tribal FQHCs. The trigger is the claim submission date, not a new date-of-service limit, and the notice says updated provider manual sections will be released in a future Medi-Cal Update. First reported in the October 11 edition.

High priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policyMedicare & Medicaid SweepConditional reminder

DHCS warns assisted living waiver facilities of denials and reprocessing

In a notice published October 9, 2026, the Department of Health Care Services (DHCS) said claims for Assisted Living Waiver (ALW) services may be non-payable due to non-compliance with program requirements, that it is reviewing previously paid claims, which may result in the reprocessing of claims that were erroneously paid, and that it will follow up with facilities that have non-payable claims. The notice lists what facilities must do to prevent denials, asks that inquiries give the facility name and National Provider Identifier (NPI), and sets no deadline.

High priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policyMedicare & Medicaid SweepNew in this edition

Medi-Cal readies enforcement of ordering, referring and prescribing enrollment; Medi-Cal Rx says prescriber enrollment for pharmacy claims starts in 2027

On November 12, 2026, Medi-Cal Dental published a special provider bulletin on ordering, referring and prescribing (ORP) enrollment. It restates that providers who order, refer or prescribe for Medi-Cal members must be enrolled in Medi-Cal with their Type 1 National Provider Identifier (NPI) through the Provider Application and Validation for Enrollment (PAVE) system, and says the Department of Health Care Services (DHCS) has published resources to help providers prepare for upcoming ORP enrollment enforcement, including a September 24, 2026 town hall on the planned timeline for claim edit activation. The Medi-Cal Rx Monthly Bulletin of November 1, 2026 says that beginning in 2027, pharmacy claims will be processed and paid only if the individual prescriber on the claim is enrolled in Medi-Cal with an individual (Type 1) NPI, a requirement that also covers pharmacists prescribing under their own authority. The bulletin says managed care plan affiliation or Medicare enrollment does not satisfy the requirement and tells prescribers not yet enrolled to apply immediately. The September 24, 2026 town hall deck says enforcement will be phased by claim type for medical claims and Medi-Cal Rx pharmacy claims, beginning in February 2027 and currently planned for completion in the second quarter of 2028, and that once enforcement is implemented claims will deny if enrollment requirements are not met. Community inpatient and outpatient hospitals and county hospitals are among the provider types the deck lists for the February 2028 ordering and referring phase, and DHCS plans a go or no-go readiness review before each phase.

Medium priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policyMedicare & Medicaid SweepNew in this edition

CMS offers states an optional hold harmless period through June 30, 2027 for the Medicaid work requirement that starts January 1, 2027

On November 13, 2026, the Centers for Medicare & Medicaid Services (CMS) announced an optional hold harmless period through and including June 30, 2027 for the Medicaid work requirement. States that use it will still assess whether people meet the requirement or are excluded, but will not deny applications or disenroll otherwise eligible people solely for failing to meet it. CMS also strongly encouraged states to maximize automated verification with data they already hold and to send clear, timely notices. The release links to federal guidance on Medicaid.gov for details of the hold harmless period. The guidance is State Medicaid Director (SMD) letter 26-006, dated November 13, 2026. A state requests the period as an optional strategy in its mitigation plan, CMS approves it as part of that plan, and a state need not use it for the whole period. For applications submitted and renewals initiated after the period ends in the state, the state must deny or terminate eligibility when an applicable individual is found ineligible for not meeting the requirement.

Medium priority · Nov 15, 2026 editionRead story →

Medi-Cal & Medicaid policyMedicare & Medicaid SweepNew in this edition

Medi-Cal Rx sets 340B billing rules for drugs under HRSA's revised Rebate Model Pilot starting January 1, 2027

On November 1, 2026, Medi-Cal Rx issued an alert on the Health Resources and Services Administration (HRSA) 340B Rebate Model Pilot Program. HRSA announced a revised Pilot on July 31, 2026, with approved rebate plans scheduled to take effect January 1, 2027; participating manufacturers may provide the 340B ceiling price through a post-purchase rebate instead of an upfront discount. From January 1, 2027, pharmacy providers may submit Medi-Cal Rx 340B claims for Pilot drugs using the 340B ceiling price in effect on the date of service plus the professional dispensing fee, and must reverse and resubmit claims when the net actual acquisition cost after the rebate differs.

Medium priority · Nov 15, 2026 editionRead story →

Provider operations 3 articles and reminders

Provider operationsMedicare & Medicaid SweepConditional reminder

Hospice election addendum: mandatory since October 1; CMS enforcement discretion on missing or incomplete addenda ends December 31

CMS made the hospice election statement addendum mandatory for every hospice election on or after October 1, 2026, in the FY 2027 Hospice Prospective Payment System final rule: it must be furnished in writing within 5 calendar days of the election effective date, updates within 3 calendar days of a plan-of-care change, and a valid signed addendum in the record is a condition for payment. From October 1 to December 31, 2026, CMS is exercising enforcement discretion, under which Medicare Administrative Contractors (MACs) will not deny claims solely because the addendum is missing or incomplete; furnishing it remains required.

High priority · Nov 15, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepConditional reminder

CDPH AFL 26-34 (dated November 9): CDPH says it will send Medi-Cal revalidation intent letters to facilities beginning November 9; no response within 35 calendar days means termination from Medi-Cal

The California Department of Public Health (CDPH) All Facilities Letter (AFL) 26-34, dated November 9, 2026, says that beginning that day CDPH will send Medi-Cal revalidation intent letters to each health care facility, asking enrolled providers to revalidate or voluntarily withdraw, and that failure to respond to the intent letter within 35 calendar days will result in termination and deactivation from the Medi-Cal program.

High priority · Nov 15, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepNew in this edition

CMS: new law limits Medicare eligibility by immigration status; coverage terminations no earlier than February 1, 2027

The Medicare Learning Network (MLN) Connects newsletter of November 12, 2026 says that recent changes to the law under the Working Families Tax Cut legislation limit Medicare eligibility to United States citizens or nationals, lawful permanent residents, Cuban and Haitian entrants and Compact of Free Association migrants, who must also meet the other Medicare eligibility requirements. The Social Security Administration (SSA) will mail notices to affected patients, and CMS says coverage terminations will occur no earlier than February 1, 2027. CMS tells Original Medicare providers to identify eligibility through the Health Insurance Portability and Accountability Act (HIPAA) Eligibility Transaction System (HETS), while Medicare Advantage organizations will inform their providers about enrollee eligibility. CMS adds that patients who lose Medicare under the new rules because of immigration status will not be eligible for assistance to pay for a Marketplace plan.

Medium priority · Nov 15, 2026 editionRead story →

More matters and continuing watch

Billing & payment 2 articles and reminders

Coverage & clinical policy 2 articles and reminders

Medi-Cal & Medicaid policy 1 articles and reminders

Provider operations 4 articles and reminders

Audits & program integrity 1 articles and reminders

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies